Literature DB >> 19668155

J&J's billion dollar punt on anti-amyloid antibody.

Cormac Sheridan.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19668155     DOI: 10.1038/nbt0809-679

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.

Authors:  Rachelle S Doody; Svetlana I Gavrilova; Mary Sano; Ronald G Thomas; Paul S Aisen; Sergey O Bachurin; Lynn Seely; David Hung
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

  1 in total
  3 in total

1.  Hope for anti-amyloid antibodies surges, yet again.

Authors:  Chris Morrison
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

2.  Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Krishnan M Dhandapani; Hedy Folkersma; Roger F Butterworth; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

3.  Effective Theranostic Cyanine for Imaging of Amyloid Species in Vivo and Cognitive Improvements in Mouse Model.

Authors:  Yinhui Li; Chen Chen; Di Xu; Chung-Yan Poon; See-Lok Ho; Rui Zheng; Qiong Liu; Guoli Song; Hung-Wing Li; Man Shing Wong
Journal:  ACS Omega       Date:  2018-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.